Cargando…
Retraction Note to: Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells
Autores principales: | Panka, David J., Liu, Qingjun, Geissler, Andrew K., Mier, James W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194038/ https://www.ncbi.nlm.nih.gov/pubmed/34116693 http://dx.doi.org/10.1186/s12943-021-01379-7 |
Ejemplares similares
-
Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b(+)/Gr-1(+) myeloid derived suppressor cells
por: Panka, David J, et al.
Publicado: (2013) -
Retraction Note to: Differential modulatory effects of GSK-3b and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma
por: Liu, Qingjun, et al.
Publicado: (2021) -
Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma
por: Liu, Qingjun, et al.
Publicado: (2011) -
Retraction: metastatic collecting duct carcinoma of the kidney treated with Sunitinib
por: Tazi, El Mehdi, et al.
Publicado: (2011) -
Retraction: Rehmannia Glutinosa Extract Activates Endothelial Progenitor Cells in a Rat Model of Myocardial Infarction through a SDF-1 α/CXCR4 Cascade
Publicado: (2019)